Yu (Amy) Zong, Shanghai Jiaotong University School of Medicine, discusses a meta-analysis of nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as neoadjuvant chemotherapy of breast cancer.
Yu (Amy) Zong
Advertisement
Articles by Yu (Amy) Zong
Advertisement
Latest Updated Articles
Nab-Paclitaxel as Neoadjuvant Therapy for Breast CancerJanuary 9th 2017
Advertisement
Advertisement
Trending on OncLive
1
FDA Finalizes 3 Guidance Documents to Broaden Cancer Clinical Trial Eligibility Criteria
2
Innovative Screening Approaches, Targeted Therapies, and Team-Based Care Drive Head and Neck Oncology Advances
3
AI Tools Show Early Promise Across Drug Discovery, Clinical Decision-Making in Lung Cancer
4
HR-Positive/HER2-Negative Metastatic Breast Cancer: Treatment Sequencing After Adjuvant Endocrine Therapy and Transitioning Beyond Endocrine-Based Approaches
5